Manuscript Publications

Click on a year to expand the list of publications. 

Keuroghlian AS, Marc L, Goldhammer H, Massaquoi M, Downes A, Stango J, Bryant H, Cahill S, Perez AC, Head JM, Mayer KH, Myers J, Rebchook GM, Bourdeau B, Psihopaidas D, Chavis NS & Cohen SM. (2024). A peer-to-peer collaborative learning approach for the implementation of evidence-informed interventions to improve HIV-related health outcomes. AIDS Behav (online ahead of print).

Lester M, Scanlon F & Batastini A. (In Press). Doubling down on dosage: Exploring the interplay between dosage effects, antisocial traits, treatment attitudes, and recidivism-related therapy outcomes. Journal of Criminal Psychology. 

Lim C, Donovan A, Freudenreich S, Cather C, Maclaurin S & Freudenreich O. (In Press). Second opinions in psychotic disorders: Delivering stage-specific recommendations. Psychiatric Services.

Liu J, Knoll SJ, Pascale MP, Gray C, Bodolay A, Potter K, Gilman J, Evins AE & Schuster RM. (In Press). Nicotine and cannabis use are common among adolescents, but so is readiness to change. Addictive Behaviors. 

Scanlon F, Morgan RD & Aceves D. (In Press). Stakeholder perceptions of implementing a treatment for people with serious mental illness in jail: Mixed-methods findings on feasibility and acceptability. Administration and Policy in Mental Health and Mental Health Services Research.  

Winickoff J, Evins AE & Levy S. (In Press). Treating youth for electronic cigarette use. JAMA Insights: Clinical Update.

Winickoff J, Levy S & Evins AE. (In Press) Vaping/e-cigarette use in adolescents. JAMA. 

Amonoo H, Onyeaka H, Onyema C & Evins AE(2024). Associations between health-related use of social media and positive lifestyle behaviors: Findings from a representative sample of US adult smokers. Subst Use Misuse. 2024;59(4):527-535.

Browne J, Elbogen EB, Mueser KT, Rudolph JL, Wu WC, Philip NS, Mills WL, Young AS, Sloane R & Hall KS. (2024). Trajectories of physical function changes for older veterans with serious mental illness in a clinical exercise program. Mental Health and Physical Activity, 26, 100580.

Charlton BM, Potter J, Keuroghlian AS, Dalrymple JL, Katz-Wise SL, Guss CE, Phillips WR, Jarvie E, Maingi S, Streed C, Anglemyer E, Hoatson T & Birren B. (2024). Development of a mentor training curriculum to support LGBTQIA+ health professionals. J Clin Transl Sci; 8(1):e44.

Chinbunchorn T, Mayer KH, Campbell J, King D, Krakower D, Marcus JL, Grasso C & Keuroghlian AS. (2024). HIV Pre-exposure prophylaxis provision by U.S. health centers in 2021. AIDS, 38(3):415-420.

Cooke ME, Knoll SJ, Streck JM, Potter K, Lamberth E, Rychik N, Gilman JM, Evins AE & Schuster RM. (2024). Contingency management is associated with positive changes in attitudes and reductions in cannabis use even after discontinuation of incentives among non-treatment seeking youth. Drug and Alcohol Dependence, 256, 111096.

DeTore NR, Burke A, Nyer M, & Holt DJ. (2024). A brief resilience-enhancing intervention and loneliness in at-risk young adults: A secondary analysis of a randomized clinical trial. JAMA Network Open, 7(2), e2354728.

Donovan AL, Vyas CM, Petriceks A, Paudel S, Van Alphen MU & Stern TA. (2024). Assessment and treatment of abnormal involuntary Movements. Harv Rev Psychiatry, 32(2), 47-57.

Keuroghlian AS. (2024). Cisgender privilege in public health research. Am J Public Health, 114(2), 142–143.

Meza BPL, Pollack CE, Tilchin C, Jennings JM, Latkin CA, Cather C, Dickerson F, Evins AE, Wang NY, Daumit GL, Yuan C & Gudzune KA. (2024). Social networks of people with serious mental illness who smoke: Potential role in a smoking cessation intervention. Journal of Mental Health, 1–10.

Mosier-Mills A, Kim H & Keuroghlian AS. (2024). Removing barriers and honoring autonomy: Rethinking mental health professional assessments in adolescent gender-affirming medical care. Harvard Review of Psychiatry, 32(3), 96–100.

Pletta DR, Austin SB, Chen JT, Radix AE, Keuroghlian AS, Hughto JMW & Reisner SL. (2024). Lower levels of social support are associated with risk for future suicide attempts in a clinical sample of transgender and gender diverse adults. Soc Psychiatry Psychiatr Epidemiol. Advance online publication.

Reisner SL, Deutsch MB, Mayer KH, Campbell J, Potter J, Keuroghlian AS, Hughto JMW, Asquith A, Pardee DJ, Harris A, Quint M, Grasso C, Gonzalez A & Radix A. (2024). Decreased anogenital gonorrhea and chlamydia in transgender and gender diverse primary care patients receiving gender-affirming hormone therapy. J Gen Intern Med, 39(7), 1164–1172.

Sandhu S, Liu M & Keuroghlian AS. (2024). Strategies for insurers to promote sexual and gender minority health. JAMA Health Forum5(4), e240439.

Schnabel D & Keuroghlian AS. (2024). Clinical considerations for children of lesbian, gay, bisexual, transgender, queer, intersex, asexual, and all sexually and gender diverse families. LGBT Health.Epub ahead of print.

Shin A, Kathrins M & Keuroghlian AS. (2024). Systemic barriers to fertility preservation for sexually and gender diverse populations. LGBT Health, 10.1089/lgbt.2023.0317. Advance online publication.

Streck JM, Potter K, Pachas GN, Cather C, Nielsen L & Evins AE. (2024). Alternative combusted tobacco product and multiple tobacco product use among individuals with serious mental illness enrolled in a large pragmatic randomized controlled trial. Addict Behav, 148, 107844.

Tervo-Clemmens B, Bentley K, Smoller JW, Nock M, Evins AE, Gilman JM & Schuster RM. (2024). Substance use is dose dependently associated with suicidal thoughts and psychiatric comorbidities. JAMA pediatrics, 178(3), 310–313.

Blajeski S, Smith MJ, Harrington M, Johnson J, Oulvey EA, Mueser KT, McGurk SR, & Razzano LA. (2023). Critical elements in the experience of virtual reality job interview training for unemployed individuals with serious mental illness: Implications for IPS supported employment. Psychiatric rehabilitation journal, 10.1037/prj0000574. Advance online publication.

Botello R, Gill K, Mow JL, Leung L, Mote J, Mueser KT, Gard DE & Fulford D. (2023). Validation of the Social Effort and Conscientious Scale (SEACS) in schizophrenia. J Psychopathol Behav Assess

Bruno J, Vedilago V, Goldhammer H, Campbell J & Keuroghlian AS. (2023). TransECHO: A national tele-education program for expanding transgender and gender diverse health care. LGBT Health10(6).

Butler W, Kim H & Keuroghlian AS. (2023). Psychiatric boarding of transgender and gender diverse youth awaiting treatment. LGBT Health10(6).

Cooke ME, Potter KW, Jashinski J, Pascale M, Schuster RM, Tervo-Clemmens B, Hoeppner BB, Pachas GN, Evins AE, Gilman JM. (2023). Development of cannabis use disorder in medical cannabis users: A 9-month follow-up of a randomized clinical trial testing effects of medical cannabis card ownership. Front Psychiatry14.

Daumit GL, Evins AE, Cather C, Dalcin AT, Dickerson FB, Miller ER 3rd, Appel LJ, Jerome GJ, McCann U, Ford DE, Charleston JB, Young DR, Gennusa JV 3rd, Goldsholl S, Cook C, Fink T & Wang NY. (2023). Effect of a Tobacco Cessation Intervention Incorporating Weight Management for Adults With Serious Mental Illness: A Randomized Clinical Trial. JAMA Psychiatry80(9):895–904.

Delman J, Arntz D, Whitman A, Skiest H, Kritikos K, Alves P, Chambers V, Markley R, Martinez J, Piltch C, Whitney-Sarles S, London J, Shtasel D & Cather C. (2023). Using community-based participatory research to conduct a collaborative needs assessment of mental health service users: Identifying research questions and building academic-community trust. Health Promotion Practice

Dickerson F, Goldsholl S, Yuan CT, Dalcin AT, Eidman B, Minahan E, Gennusa JV, Mace E, Cullen B, Evins AECather C, Wang NY, McGinty EM & Daumit GL. (2023). Promoting evidence-based tobacco cessation treatment in community mental health clinics: Protocol for a pilot study. JMIR Research Protocols, 12:e44787.

Donovan AL, Petriceks AH, Paudel S, Vyas CM & Stern TA. (2023). Use of physical restraints in the emergency department: Rationale, risks, and benefits. The Primary Care Companion for CNS disorders25(3), 22f03320.

Donovan AL, Vyas CM, Petriceks A, Paudel S, Van Alphen MU & Stern TA. (2023). Drug-induced abnormal involuntary movements: Prevalence and treatment. The Primary Care Companion for CNS disorders25(3):22f03305.

Foo CYS, Gaudiano BA, Friedman-Yacoobian M & Yen S. (2023). Acceptance-based Parent Training Intervention for Youths with Co-occurring Psychotic Symptoms and Suicidal Behaviors: A Case Series from an Open Trial. International Journal of Cognitive Behavioral Therapy.

Forcen F & Freudenreich O. (2023). Coping with pandemics: A historical perspective about society’s tools to deal with global infectious diseases. The Journal of Nervous and Mental Disease211(12), 927-933.

Fortuna KL, Lebby S, Geiger P, Johnson D, MacDonald S, Chefetz I, Ferron JC, St George L, Rossom R, Kalisa J, Mestrovic T, Nicholson J, Pringle W, Rotondi AJ, Sippel LM, Sica A, Solesio ME, Wright M, Zisman-Ilani Y, Cather C & Walker R. (2023). Lived experience–led research agenda to address early death in people with a diagnosis of a serious mental illness. JAMA Netw. Open, 6(5):e2315479.

Guy AA, Surace A, Zelaya DG, Flynn R, Opalo C, Keuroghlian AS, Mayer KH, Monti PM & Kahler CW. (2023). Transgender and gender diverse adults’ reflections on alcohol counseling and recommendations for providers. American Journal of Orthopsychiatry.   

Kamal K, Keuroghlian AS & Potter J. (2023). Promoting sexual and gender minority health clinical skills training for all medical students. Academic Medicine: Journal of the Association of American Medical Colleges, 98(9), 987-993).

Kamal K, Li JJ & Keuroghlian AS. (2023). Addressing the physical and mental impacts of post-surgical scarring among transgender and gender diverse people. LGBT Health.

Lu W, Caldwell B, Gao N, Oursler J, Wang K, Beninato J, Srijeyanthan J, Kumi C, Sawyer J, Giacobbe G & Mueser KT(2023). Healing trauma while staying at home: Using telehealth to conduct a brief treatment program for PTSD.  Journal of Psychosocial Nursing and Mental Health Services, 0(0):1–11.

Liu M, King D, Mayer KH, Grasso C & Keuroghlian AS. (2023). Sexual orientation and gender identity data completeness at US federally qualified health centers, 2020 and 2021. American Journal of Public Health, e1–e10.

Liu M, Sandhu S, Reisner SL, Gonzales G & Keuroghlian AS. (2023). Health status and healthcare access among lesbian, gay, and bisexual adults in the US, 2013-2018. JAMA Intern Med

Loo S, Peretti M, Sigal M, Noe B, Grasso C, Keuroghlian AS & Mayer KH. (2023). Health center leadership perspectives regarding barriers to and facilitators of providing culturally responsive care for sexual and gender minority patients. LGBT Health. Online ahead of print.

Nagendra A, Black C & Penn DL. (2023). Black Americans and schizophrenia: Racism as a driver of inequities in diagnosis, assessment, and treatment. Schizophrenia Research253, 1–4.

Nagendra A, Liu C-WJ, Mueser KT, Harvey PD, Depp C, Moore R, Davis B, & Pinkham A. (2023). Do symptom severity, individual socioeconomic status, and neighborhood socioeconomic status explain differences in daily functioning in non-Latinx Black, non-Latinx white, and Latinx people with serious mental illnesses? Clinical Psychological Science0(0).

Nagendra A, Weiss DM, Merritt C, Cather C, Sosoo EE, Mueser KT & Penn DL. (2023). Clinical and psychosocial outcomes of Black Americans in the Recovery After an Initial Schizophrenia Episode Early Treatment Program (RAISE-ETP) study. Social psychiatry and psychiatric epidemiology58(1), 77–89.

Ng LC, Miller AN, Bowers G, Cheng Y, Brigham R, Tai MH, Smith AM, Mueser KT, Fortuna LR & Coles M. (2023). A pragmatic feasibility trial of the Primary Care Intervention for PTSD: A health service delivery model to reduce health disparities for low-income and BIPOC youth. Behaviour Research and Therapy, 165, 104310.

Ørjasæter KB & Mueser KT. (2023). Meaningful goal setting: Practitioners’ perspectives on goal setting in the illness management and recovery program. Psychiatric Rehabilitation Journal, 46(1), 94-100.

Orozco-Poore C & Keuroghlian AS. (2023). Neurological considerations for “nerve-sparing” cosmetic genital surgeries performed on children with xx chromosomes diagnosed with 21-hydroxylase congenital adrenal hyperplasia and clitoromegaly. LGBT Health, 8(10).

Paudel S, Donovan AL, Petriceks A, Vyas CM, Van MU & Stern TA. (2023). Drug-induced abnormal involuntary movements: Prevalence and treatment. The Primary Care Companion for CNS Disorders25(3), 22f03305.

Schwartz KR, Donovan AL, Hayes BD, Uchida M & Rosen JB. (2023). Case 16-2023: A 13-year-old boy with depression and hypotension. The New England Journal of Medicine, 388(21), 1992–1999.

Scott K, Guy AA, Zelaya DG, Surace A, Elwy AR, Keuroghlian AS, Mayer KH, Monti PM & Kahler CW. (2023). Research and engagement considerations for alcohol use telehealth services within HIV care: A qualitative exploration on federally qualified health centers. AIDS Care.

Senay O, Seethaler M, Makris N, Yeterian E, Rushmore J, Cho KIK, Rizzoni E, Heller C, Pasternak O, Szczepankiewicz F, Westin CF, Losak J, Ustohal L, Tomandl J, Vojtisek L, Kudlicka P, Kikinis Z, Holt DJ, Lewandowski KE, Lizano P, Keshavan MS, Öngür D, Kasparek T, Breier A, Shenton ME, Seitz-Holland J & Kubicki M. (2023). A preliminary choroid plexus volumetric study in individuals with psychosis. Hum Brain Mapp. 44(6):2465-2478.

Shuster R, Cather C, Pachas GN, Neilsen L, Iroegbulem V, Dufour J, Potter K, Levy S, Gray K & Evins AE. (2023). A randomized controlled trial of varenicline and brief behavioral counseling delivered by lay counselors for adolescent vaping cessation: Study protocol. Frontiers in Psychiatry14, 1083791.

Smith MJ, Burke-Miller JK, Bornheimer LA, Ross B, Bell MD, McGurk SR, Mueser KT, Nelson K, Brown A, Prestipino J, Borghani N & Razzano LA. (2023). Psychometric properties of the mock interview rating scale for schizophrenia and other serious mental illnesses. Frontiers in psychiatry, 14, 1150307.

Tervo-Clemmens B, Schmitt W, Wheeler G, Cooke ME, Schuster RM, Hickey S, Pachas GN, Evins AE & Gilman JM. (2023). Cannabis use and sleep quality in daily life: An electronic daily diary study of adults starting cannabis for health concerns. Drug and alcohol dependence243, 109760.

Turban JL, Dolotina B, Freitag TM, King D & Keuroghlian AS. (2023). Age of realization and disclosure of gender identity among transgender adults. The Journal of Adolescent Health : Official publication of the Society for Adolescent Medicine72(6), 852–859.

Van Alphen, MU, Lim C & Freudenreich O. (2023). Mobile vaccine clinics for patients with serious mental illness and health care workers in outpatient mental health clinics. Psychiatr Serv.

Vyas CM, Petriceks AH, Paudel S, Donovan AL, & Stern TA. (2023). Acute psychosis: Differential diagnosis, evaluation, and management. The Primary Care Companion for CNS Disorders25(2), 22f03338.

Wright AC, Palmer-Cooper E, Cella M, McGuire N, Montagnese M, Dlugunovych V, Liu CJ, Wykes T & Cather C. (2023). Experiencing hallucinations in daily life: The role of metacognition. Schizophrenia Research265, 74-82.

Alegria M, Falgas-Bague I, Fukuda M, Zhen-Duan J, Weaver C, O’Malley I, Layton T, Wallace J, Zhang L, Lapatin Markle S, Neighbors C, Lincourt P, Hussain S, Manseau M, Stein B, Rigotti N, Wakeman S, Kane M, Evins AE, McGuire T. (2022). Performance metrics of substance use disorder care among Medicaid enrollees in New York City: Your managed care plan can make a difference. JAMA health forum, 3(7), e221771.

AS Keuroghlian, Keatley J, Shaikh S & Radix AE. (2022). The context, science, and practice of gender-affirming care. Nature Medicine28(12), 2464–2467.

Browne J, Cather C & Ponce AN. (2022). A preliminary study of clinical psychology doctoral students’ training in food insecurity assessment and resource provision. Journal of Health Care for the Poor and Underserved33(2), 623–632.

Clauss J, Bhiku K, Burke A, Pimentel-Diaz Y, DeTore N, Zapetis S, Zvonar V, Kritikos KCanenguez KCather C & Holt D. (2022). Development of a transdiagnostic, resilience-focused intervention for at-risk adolescents. Journal of Mental Health, 32(3), 592-601.

Cooke ME, Clifford JS, Do EK, Gilman J, Maes HH, Peterson RE, Prom-Wormley EC, Spit for Science Working group, Evins AE, Schuster RM. (2022). Polygenic score for cigarette smoking is associated with ever electronic-cigarette use in a college-aged sample. Addiction (Abingdon, England)117(4), 1071–1078.

de Leon J, Schoretsanitis G, Smith RL, Molden E, Solismaa A, Seppälä N, Kopeček M, Švancer P, Olmos I, Ricciardi C, Iglesias-Garcia C, Iglesias-Alonso A, Spina E, Ruan CJ, Wang CY, Wang G, Tang YL, Lin SK, Lane HY, Kim YS, …Freudenreich O, …Müller DJ. (2022). An international adult guideline for making clozapine titration safer by using six ancestry-based personalized dosing titrations, CRP, and clozapine levels. Pharmacopsychiatry55(2), 73–86.

DeTore NR, Bain K, Wright A, Meyer-Kalos P, Gingerich S, & Mueser KT. (2022). A randomized controlled trial of the effects of early intervention services on insight in first episode psychosis. Schizophrenia Bulletin48(6), 1295-1305.

DeTore NR, Balogun-Mwangi O, Tepper M, Cather C, Russinova Z, Lanca M & Mueser KT. (2022). The interrelationships of motivation, positive symptoms, stigma, and role functioning in early psychosis.Early Intervention in Psychiatry16(7), 736–743.

DeTore NR, Luther L, Deng WY, Zimmerman JE, Leatham L, Burke A, Nyer MB, Holt DJ. (2022). Efficacy of a transdiagnostic, prevention-focused program for at-risk young adults: a waitlist-controlled trial. Psychological Medicine, 1–10.

Donovan AL, Vyas CM, Petriceks A, Paudel S, Van MU & Stern TA. (2022). Agitation and an altered mental status in the emergency department: Differential diagnosis, evaluation, and treatment. The primary care companion for CNS disorders24(6), 22f03277.

Dotson S, Johnson-Arbor K, Schuster R, Tervo-Clemmens B, Evins AE. (2022). Unknown risks of psychosis and addiction with delta-8-THC: A call for research, regulation, and clinical caution. Addiction (Abingdon, England)117(9), 2371–2373.

Eryilmaz H, Pax M, O’Neill AG, Vangel M, Diez I, Holt DJ, Camprodon JA, Sepulcre J & Roffman JL. (2022). Network hub centrality and working memory performance in schizophrenia. Schizophrenia (Heidelberg, Germany)8(1), 76.

Evins AE & Cather C. (2022). Addressing barriers to provision of first-line pharmacotherapy for tobacco use disorder. Psychiatric Services, 74(4), 429-430.

Evins AE, Cather C, Maravic MC, Reyering S, Pachas GN, Thorndike AN, Levy DE, Fung V, Fischer MA, Schnitzer K, Pratt S, Fetters MD, Deeb B, Potter K, Schoenfeld DA. (2022). A pragmatic cluster randomized trial of provider education and community health worker support for tobacco cessation. Psychiatric services (Washington, D.C.), 74(4), 365–373.

Fortuna KL, Wright A, Mois G, Myers A, Kadakia A & Collins-Pisano C. (2022). Feasibility, acceptability, and potential utility of peer-supported ecological momentary assessment among people with serious mental illness: A pilot study. The Psychiatric Quarterly93, 717-735.

Foulds J, Veldheer S, Pachas G, Hrabovsky S, Hameed A, Allen SI, Cather C, Azzouz N, Yingst J, Hammett E, Modesto J, Krebs NM, Lester C, Trushin N, Reinhart L, Wasserman E, Zhu J, Liao J, Muscat JE, Richie JP, Jr, … Evins AE. (2022). The effects of reduced nicotine content cigarettes on biomarkers of nicotine and toxicant exposure, smoking behavior and psychiatric symptoms in smokers with mood or anxiety disorders: A double-blind randomized trial. PloS one17(11), e0275522.  

Gilman JM, Schmitt W, Potter K, Kendsior B, Pachas GN, Hickey S, Makary M, Huestis MA, Evins AE. (2022). Identification of delta-9 tetrahydrocannabinol intoxication using functional brain imaging. Neuropsychopharmacology, 47, 944–952.

Gilman JM, Schuster RM, Potter K, Schmitt W, Wheeler G, Pachas GN, Hickey S, Cooke ME, Dechert A, Plummer R, Tervo-Clemmens B, Schoenfeld DA, Evins AE. (2022). Effect of medical marijuana card ownership on pain, insomnia, and affective disorder symptoms in adults: A randomized controlled trial. JAMA Network Open5(3), e222106.

Holt DJ, Zapetis SL, Badabi B, Zimmerman JE &Tootell RBH. (2022).  Personal space increases during the COVID-19 pandemic in response to real and virtual humans. Frontiers in Psychology, 14, 952998.

Japuntich SJ, Adkins-Hempel M, Lundtvedt C, Becker SJ, Helseth SA, Fu SS, Tidey J, Evins AE & Pratt R. (2022). Implementing chronic care model treatments for cigarette dependence in community mental health clinics. Journal of dual diagnosis, 18(3), 153–164.

Jashinski J, Evins AE, Gilman J. (2022). A randomized, pragmatic, waitlist-controlled trial of cannabis added to prescription opioid support on opioid dose reduction and pain in adults with chronic non-cancer pain: Study protocol. BMJ open, 12(6), e064457.

Keuroghlian AS & Radix AE. (2022). A cautionary tale: The doomed gender identity clinic at Johns Hopkins Hospital. Annals of internal medicine175(10), 1483–1484.

Kim G-W, Farabaugh AH, Vetterman R, Holmes A, Nyer M, Nasiriavanaki Z, Fava M, Holt DJ. (2022). Diminished frontal pole size and functional connectivity in young adults with high suicidality. Journal of Affective Disorders310, 484–492.

Lim C, Donovan A, Harrold G & Freudenreich O. (2022). A case of undetected seizure disorder that exacerbated catatonia and treatment-resistant schizophrenia: Comprehensive evaluation is key. Prim Care Companion CNS Disord, 24(00):22cr03282.  

Lim C, Van Alphen M, Maclaurin S, Mulligan C, Macri B, Cather C, Freudenreich O (2022). Increasing COVID-19 vaccination rates among patients with serious mental illness: A pilot intervention study. Psychiatric Services (Washington, D.C.)73(11), 1274-1277.

Onyeaka HK, Seeber R, Anugwom G, Oladunjoye AF, Kekere V, Firth J & Evins AE. (2022). Association between court-ordered corrective statements and smoking cessation among individuals with depression or anxiety. Psychiatry Research Communications, 2(4), 100091.

Qi W, Marx J, Zingman M, Li Y, Petkova E. Blessing E, Ardekani B, Kani SA, Cather C, Freudenreich O, Holt D, Zhao J, Wang J & Goff DC. (2022). Hippocampal subfield volumes predict disengagement from maintenance treatment in first episode schizophrenia. Schizophrenia Bulletin49(1), 34–42.

Srinivasan S, Goldhammer H, Crall C, Kitts R & Keuroghlian AS. (2022) A novel medical student elective course in lesbian, gay, bisexual, transgender, queer, intersex, asexual, and sexually and gender diverse health: Training tomorrow’s physician-leaders. LGBT Health10(3), 252–257.

Tootell RBH, Nasiriavanaki Z, Babadi B, Greve DN, Nasr S & Holt DJ. (2022). Interdigitated columnar representation of personal space and visual space in human parietal cortex. J Neurosci.

Wright AC, Browne J, Cather C, Meyer-Kalos P & Mueser KT. (2022) Relationship between patterns of cannabis use and functional and symptomatic trajectories in first-episode psychosis. Eur Arch Psychiatry Clin Neurosci (2022).

Wright AC, Cather C, Mueser KT, Farabaugh A, Terechina O, Fava M & Holt D. (2022). Relationships among subclinical psychotic symptoms in young adults over time. Psychiatry Research, 314, 114617.

Wright AC, Kritikos K, Bhiku K, LeFeber L, Skiest H, Whitman A, Browne J, Arntz D, Fortuna KL, Mueser KT, Cather C. (2022). The impact of the COVID-19 pandemic on peer specialists. Psychiatric Rehabilitation Journal, 45(3), 201–211.

Wright AC, Moody E, Browne J & Cather C. (2022). Self-defining memories among persons with mental health, substance use, cognitive, and physical health conditions: a systematic review. Memory (Hove, England), 30(7), 823–844.

Wu CA & Keuroghlian AS. (2022). Moving beyond psychiatric gatekeeping for gender-affirming surgery. JAMA surgery158(3), 231–232.

Zapetis SZ, Nasiriavanaki Z, Luther L, Holt DJ. (2022). Neural correlates of variation in personal space and social functioning in schizophrenia and healthy individuals. Schizophrenia Bulletin.

Zimmerman J, DeTore NR, Deng W, Burke AS, Nyer M, Holt DJ. (2022). Worsening of psychotic experiences in college students during the COVID-19 pandemic. Schizophrenia Research256, 133–135.

Bergman B, Fava M, Evins AE & Kelly JF (2021). Online recovery support meetings can help mitigate the public health consequences of COVID-19 for individuals with substance use disorder. Addictive behaviors, 113, 106661.

Browne J, Cather C & Mueser K. (2021). Common factors in psychotherapy. Oxford Research Encyclopedia of Psychology. doi: 10.1093/acrefore/9780190236557.013.79

Browne J, Cather C, Zvonar V, Thayer K, Skiest H, Arntz D, Kritikos K, Schnitzer K, Brown HE, Evins AEDonovan AL. (2021). Developing a sound body: Open trial results of a group healthy lifestyle intervention for young adults with psychosis. Community Mental Health Journal57(5):864-871.

Browne J, Mccurley JL, Fung V, Levy DE, Clark CR & Thorndike AN. (2021). Addressing social determinants of health identified by systemic screening in a Medicaid accountable care organization: A qualitative study. Journal of Primary Care & Community Health, 12:1-8. doi: 10.1177/2150132721993651

Browne J, Wright AC, Berry K, Mueser KT, Cather C, Penn DL & Kurtz M. (2021). The alliance-outcome relationship in individual psychosocial treatment for schizophrenia and early psychosis: A meta-analysis. Schizophrenia Research, 231:154-163. doi: 10.1016/j.schres.2021.04.002

Buck B, Emily EC, Halverson TF, Nagendra A, Ludwig KA, Fortney JC. (2021) A systematic search and critical review of studies evaluating psychometric properties of patient-reported outcome measures for schizophrenia. Journal of Psychiatric Research, 147, 13-23.

Cooke ME, Gilman JM, Lamberth E, Rychik N, Tervo-Clemmens B, Evins AE, Schuster RM. (2021). Assessing changes in symptoms of depression and anxiety during four weeks of cannabis abstinence among adolescents. Frontiers in Psychiatry12, 689957.

Dotson S, Ogbu-Nwobodo L & Shtasel D. (2021). The importance of an evidence-based structural approach in public and community psychiatry. Psychiatric Annals, 51(6). doi: 10.3928/00485713-20210508-01

Evins AE, West R, Benowitz N, Russ C, Lawrence D, McRae T, Maravic MC, Heffner J & Anthenelli RM (2021). Efficacy and tolerability of pharmacotherapeutic smoking cessation aids in those with schizophrenia spectrum disorders: A subgroup analysis of EAGLES. Psychiatric Services, 72(1), 7–15.

Freudenreich O, Kontos N & Querques J. (2021). Ethics in public and community psychiatry. Psychiatric Annals, 51(6):272-277. doi: 10.3928/00485713-20210511-04

Holt DJ & DeTore NR. (2021). Prevention of psychiatric illness in the community: Seeds of change. Psychiatric Annals, 51(6):255-260. doi: 10.3928/00485713-20210511-01

Levy S, Evins AE, Schuster RM, Green L, Lunstead J, Fuller A, Needles EW, Weitzman ER. Virtual group therapy programs- The wave of the future. (2021). Journal of Adolescent Health. 69(3):527.

Lim C, Van Alphen MU & Freudenreich O. (2021). Becoming vaccine ambassadors: A new role for psychiatrists. Current Psychiatry, 20(8):10-11,17-21,26-28,38 | doi: 10.12788/cp.0155

MacLaurin SA, Ujkaj M, Mulligan C & Freudenreich O. Optimal long-acting injectable antipsychotic management during COVID-19 [Brief report]. (2021). The Journal of Clinical Psychiatry, 82(1):20|13730. doi: 10.4088/JCP.20l13730

Nagendra A, Halverson T, Pinkham AE, Harvey PD, Jarskog LF, Weisman AM & Penn DL. (2021). Black Americans with schizophrenia: The effects of neighborhood socioeconomic status on domains of functioning. Schizophrenia Research, 224, 95-101. doi: 10.1016/j.schres.2020.09.020

Oh H, Nagendra A, Besecker M, Smith L, Koyanagi A & Wang SJ. (2021). Economic strain, parental education and psychotic experiences among college students in the United States: Findings from the Healthy Minds Study 2020. Acta Early Intervention in Psychiatry,

Schnitzer K, Cather C, Potter K, Kaba H, Marsden J, Hoffman D & Shtasel D. (2021). For homeless persons with serious mental illness, can a state transitional shelter promote racial equity in housing outcomes? Journal of Healthcare for the Poor and Underserved, 32(1):232-244. doi: 10.1353/hpu.2021.0021

Schnitzer K, MacLaurin S, & Freudenreich O (2021). Long-acting injectable antipsychotics during the COVID-19 pandemic. Current Psychiatry, 20(2), 8-13. doi:10.12788/cp.0087

Surya S, Bishnoi RJ, Beesam Shashank R, Miller BJ, Freudenreich O, McEvoy JP. (2021). Monitoring for myocarditis during treatment initiation with clozapine. Acta Psychiatr Scand, 144(2):194-200. doi: 10.1111/acps.13328

Wang J, Hart KL, Qi W, Ardekani BA, Li C, Marx J, Freudenreich O, Cather C, Holt D, Bello I, Diminich ED, Tang Y, Worthington M, Zeng B, Wu R, Fan X, Zhao J, Wang J & Goff DC. (2021). Association of aripiprazole with reduced hippocampal atrophy during maintenance treatment of first-episode schizophrenia. Journal of Clinical Psychopharmacol, 41(3):244-249. doi: 10.1097/JCP.0000000000001391

Wright AC, Browne J, Skiest H, Bhiku K, Baker JT & Cather C. (2021). The relationship between conventional clinical assessments and momentary assessments of symptoms and functioning in serious mental illness: A systematic review. Schizophrenia Research. doi: 10.1016/j.schres.2021.04.010

Wright AC, Cather C, Farabaugh A, Terechina O, Pedrelli P, Nyer M., … & Holt DJ. (2021). Relationship between cannabis use and psychotic experiences in college students. Schizophrenia Research, 231, 198-204.

Wright AC, Lysaker PH, Fowler D & Greenwood K. (2021). Clinical insight in first episode psychosis: The role of metacognition. Journal of Mental Health. doi: 10.1080/09638237.2021.1922629

Wright AC, McGurk SR, Shaya Y, Feldman K & Mueser KT. (2021). Does comprehensive cognitive remediation improve emotion perception?. Cognitive Neuropsychiatry26(5), 343-356.

Abplanalp SJ, Mueser KT & Fulford D. (2020). The role of physical pain in global functioning of people with serious mental illness. Schizophrenia Research, 222, 423-428. doi: 10.1016/j.schres.2020.03.062.

Bartels SJ, Baggett TP, Freudenreich O & Bird BL. (2020). COVID-19 emergency reforms in Massachusetts to support behavioral health care and reduce mortality of people with serious mental illness. Psychiatric Services, 71(10), 1078-1081. doi: 10.1176/

Beard E, Jackson SE, Anthenelli RM, Benowitz NL, St Aubin L, McRae T, Lawrence D, Russ C, Krishen A, Evins AE & West R (2021). Estimation of risk of neuropsychiatric adverse events from varenicline, bupropion, and nicotine transdermal patch versus placebo: Secondary analysis of results from the EAGLES trial using Bayes factors. Addiction, 116(10), 2816-2824.

Browne JCather C, Zvonar V, Thayer K, Skiest H, Arntz D, Kritikos K, Schnitzer K, Brown H, Evins AE & Donovan A (2020). Developing a sound body: Open trial results of a group healthy lifestyle intervention for young adults with psychosis. Community Mental Health Journal 57(5), 864–871.

Browne J, Sanders AS, Friedman-Yakoobian M, Guyer M, Keshavan M, Kim B & Kline E. (2020). Implementation case study: Multifamily group intervention in first-episode psychosis programs. Early Intervention in Psychiatry, 1-7. doi: 10.1111/eip.13066

Burke A, Shapero BG, Pelletier-Baldelli A, Deng YW, Nyer MB, Leathem L, Namey L, Landa C, Cather C & Holt DJ (2020). Rationale, methods, feasibility, and preliminary outcomes of a transdiagnostic prevention program for at-risk college students. Frontiers in Psychiatry. doi: 10.3389/fpsyt.2019.01030

Daumit GL, Dalcin AT, Dickerson FB, Miller ER, Evins AECather C, Jerome GJ, Young DR, Charleston JB, Gennusa JV, Goldsholl S, Cook C, Heller A, McGinty EE, Crum RC, Appel LJ & Wang NY (2020). Effect of a comprehensive cardiovascular risk reduction intervention in persons with serious mental illness: A randomized clinical trial. JAMA Network Open. doi: 10.1001/jamanetworkopen.2020.7247

Donovan AL, Aaronson EL, Black L, Fisher SA, Bird SA, Benzer T & Temin ES. (2020). Keeping patients at risk for self-harm safe in the emergency department: A protocolized approach. The Joint Commission Journal on Quality and Patient SafetyS1553-7250(20)30215-4. doi: 10.1016/j.jcjq.2020.08.013

Dotson S, Hartvigsen N, Wesner T, Fricchione G, & Freudenreich O (2020). Clozapine toxicity in the setting of COVID-19. Psychosomatics61(5): 577–578.

Evins AE, West R, Benowitz N, Russ C, Lawrence D, McRae T, Maravic MC, Heffner J & Anthenelli R. (2020). Efficacy and safety of pharmacotherapeutic smoking cessation aids in schizophrenia spectrum disorders: Subgroup analysis of EAGLES. Psychiatric Services, 72(1). doi: 10.1176/

Freudenreich O, Kontos N & Querques J. (2020). COVID-19 and patients with serious mental illness. Current Psychiatry, 19(9):24-27, 33-39. doi: 10.12788/cp.0036

Gaudiano, B. A., Ellenberg, S., Ostrove, B., Johnson, J., Mueser, K. T., Furman, M., & Miller, I. W. (2020). Feasibility and preliminary effects of implementing acceptance and commitment therapy for inpatients with psychotic-spectrum disorders in a clinical psychiatric intensive care setting. Journal of cognitive psychotherapy, 34(1), 80–96.

Halstead EJ, Leavitt VM, Fiore D & Mueser KT. (2020). A feasibility study of a manualized resilience-based telehealth program for persons with multiple sclerosis and their support partners. Multiple Sclerosis Journal – Experimental, Translational and Clinical, 6(3), 2055217320941250. doi: 10.1177/2055217320941250

Halstead EJ, Stanley J, Fiore D & Mueser KT. (2020). The impact of cognitive impairment in adults with multiple sclerosis (MS) and their family caregivers. International Journal of MS Care, 23(3), 93-100. doi: 10.7224/1537-2073.2019-091

Katz TC, Wozniak J & Freudenreich O. (2020). Challenges of electronic medication entry-working toward reconciliation: A case-based discussion. Psychosomatics, 61(6):808-813. doi: 10.1016/j.psym.2020.02.001

Khare C, Mueser KT, Fulford D, Watve VG, Karandikar NJ, Khare S, Karandikar DN & McGurk SR. (2020).Employment functioning in people with severe mental illnesses living in urban vs. rural areas in India. Social Psychiatry and Psychiatric Epidemiology. 55(12), 1593-1606. doi: 10.1007/s00127-020-01901-0

Marques L*, Youn S*, Zepeda ED, Chablani-Medley A, Bartuska AD, Baldwin M & Shtasel DL. (2020). Effectiveness of a modular cognitive behavioral skills curriculum in high-risk justice-involved youth. The Journal of Nervous and Mental Disease, 208(12), 925-932. doi: 10.1097/NMD.0000000000001232

Schnitzer K, Cather C, Thorndike AN, Potter K, Freudenreich O, MacLaurin S, Vilme M, Dechert A, Wexler D & Evins AE (2020). Improved glycemic control and other diabetes relevant outcomes in adults with serious mental illness and diabetes with an open sixteen-week, reverse integrated care, behavioral and educational intervention. Psychiatric Services. doi: 10.1176/

Schnitzer K, Merideth F, Macias-Konstantopoulos W, Hayden D, Shtasel D & Bird S (2020). Disparities in care: The role of race on the utilization of physical restraints in the emergency setting. Academic Emergency Medicine27(10), 943–950.

Siskind D, Honer W, Clark S, Correll C, Hasan A, Howes O, Kane J, Kelly DL, Laitman R, Lee J, Maccabe, J, Myles N, Nielsen J, Schulte F, Taylor D, Verdoux H, Wheeler A & Freudenreich O (2020). Consensus statement on the use of clozapine during the COVID-19 pandemic. Journal of Psychiatry & Neuroscience45(4), 200061. Advance online publication.

Turner DT., Reijnders M, van der Gaag M, Karyotaki E, Valmaggia LR., Moritz S, Lecomte T, Turkington D, Penadés R, Elkis H, Cather C, Shawyer F, O’Connor K, Li Z, de Paiva Barretto EM & Cuijpers P (2020). Efficacy and moderators of cognitive behavioural therapy for psychosis versus other psychological interventions: An individual-participant data meta-analysis. Frontiers in Psychiatry11. doi: 10.3389/fpsyt.2020.00402

Worthington MA, Petkova E, Freudenreich OCather CHolt D, Bello I, Diminich E, Tang Y, Ardekani BA, Zengi B, Wu R, Fan X, Zhao J, Wang J & Goff DC (2020). Air pollution and hippocampal atrophy in first episode schizophrenia. Schizophrenia Research, 218, 63–69.

Wright ACBrowne JCather C, Pratt S, Bartels S & Mueser K. (2020). Does self-efficacy predict functioning in older adults with schizophrenia? A cross-sectional and longitudinal mediation analysis. Cognitive Therapy and Research, 45, 136-148. doi: 10.1007/s10608-020-10171-8.

Wright AC, Browne J, Mueser KT, & Cather C. (2020). Evidence-Based Psychosocial Treatment for Individuals with Early Psychosis. Child and adolescent psychiatric clinics of North America, 29(1), 211–223.

Wright AC, Cather, C., & Evins AE. (2020). Role of cannabis in youth onset psychosis and the changing landscape of this topic. Child and adolescent psychiatric clinics of North America, 29(1), 145–156.

Wright AC, Coman D, Deng W, Farabaugh A, Terechina O, Cather C, Fava M & Holt D (2020). The impact of childhood trauma, hallucinations, and emotional reactivity on delusional ideation. Schizophrenia Bulletin Open. doi: 10.1093/schizbullopen/sgaa021

Youn SJ, Aguilar-Silvan Y, Baldwin M, Chablani-Medley A, Patrick KA, Shtasel DL & Marques L (2020). Ensuring the fit of an evidence-based curriculum for high-risk Latina young mothers using implementation science. Journal of Community Psychology, 49(2), 737–755.

Achtyes, E. D., Ben-Zeev, D., Luo, Z., Mayle, H., Burke, B., Rotondi, A. J., Gottlieb, J. D., Brunette, M.F., Mueser, K.T., Gingerich, S., Meyer-Kalos, P.S., Marcy, P., Schooler, N.R., Robinson, D.E., & Kane, J.M. (2019). Off-hours use of a smartphone intervention to extend support for individuals with schizophrenia spectrum disorders recently discharged from a psychiatric hospital. Schizophrenia Research206, 200-8.

Ayers CR, Heffner JL, Russ C, Lawrence D, McRae T, Evins AE & Anthenelli RM (2019). Efficacy and safety of pharmacotherapies for smoking cessation in anxiety disorders: Subgroup analysis of the randomized, active- and placebo-controlled EAGLES trial. Depression and Anxiety. doi: 10.1002/da.22982.

Browne J, Bass, E., Mueser KT, Meyer-Kalos, P., Gottlieb, J.D., Estroff, S.E., & Penn, D.L. (2019). Client predictors of the therapeutic alliance in individual resiliency training for first episode psychosis. Schizophrenia Research, 204, 375-80. doi: 10.1016/j.schres.2018.07.035

Browne J, Mueser KT, Meyer-Kalos, P., Gottlieb, J.D., Estroff, S.E., & Penn, D.L. (2019). The therapeutic alliance in individual resiliency training for first episode psychosis: Relationship with treatment outcomes and therapy participation. Journal of Consulting and Clinical Psychology, 87(8): 734-744.

DeCross, S.N., Farabaugh, A. H., Holmes, A.J., Ward, M., Boeke, E. A., Wolthusen, R. P. F., Coombs III, G., Nyer, M., Fava, M., Buckner, R. L., Holt, D. J. (2019). Increased amygdala-visual cortex connectivity in youth with persecutory ideation. Psych Med, 12:1-11. doi: 10.1017/S0033291718004221

DeTore, N. R., Gottlieb, J. D., & Mueser, K. T. (2019). Prevalence and correlates of PTSD in first episode psychosis: Findings from the RAISE-ETP study. Epub at Psychological services, 18(2), 147–153.

DeTore, N. R., Mueser, K. T., Byrd, J. A., & McGurk, S. R. (2019). Cognitive functioning as a predictor of response to comprehensive cognitive remediation. Journal of Psychiatric Research, 113: 117-24.

Evins, A. E., Cather, C., & Daumit, G. L. (2019). Smoking cessation in people with serious mental illness. The Lancet Psychiatry  

Evins AE, Cather, C., & Daumit, G. (2019). Tailored intervention to improve engagement of smokers with severe mental illness in cessation services. Lancet Psychiatry, 6(7): 563-564.

Gilman, J.M., Yücel, M.A., Pachas, G.N., Potter, K., Levar, N., Broos, H., Manghis, E.M., Schuster, R.M., & Evins A.E. (2019). Delta-9-tetrahydrocannabinol intoxication is associated with increased prefrontal activation as assessed with functional near-infrared spectroscopy: A report of a potential biomarker of intoxication. NeuroImage

Goff, D.C., Freudenreich, O.Cather, C.Holt, D., Bello, I., Diminich, E., Tang, Y., Ardekani, B.A., Worthington, M., Zeng, B., & Wu, R. (2019). Citalopram in first episode schizophrenia: The DECIFER trial. Schizophrenia research208, 331-337.

Lecomte, T., Potvin, S., Samson, C., Francoeur, A., Hache-Labelle, C., Boucher, J., Bouchard, M., Gagné, S., & Mueser, K. T. (2019). Predicting and preventing symptom onset in schizophrenia: A meta-review of current empirical evidence. Journal of Abnormal Psychology128(8):840-854.

Marques, L., Valentine, S.E., Kaysen, D., Mackintosh, M.A., De Silva, D., Louise, E., Ahles, E.M., Youn, S.J., Shtasel, D.L., Simon, N.M., & Wiltsey-Stirman, S. (2019). Provider fidelity and modifications to cognitive processing therapy in a diverse community health clinic: Associations with clinical change. Journal of consulting and clinical psychology87(4), 357.

Martinez, L.S., Lundgren, L., Walter, A.W., Sousa, J., Tahoun, N., Steketee, G., Hahm, H., Mueser KT, Krull, I., Do, D.L., & Saitz, R. (2019). Behavioral health, primary care integration, and social work’s role in improving health outcomes in communities of color: A systematic review. Journal of the Society for Social Work & Research, 10, 2334-15.

Mueser KT, DeTore NR, Kredlow M, Penn DL & Hintz K (2019). Clinical and demographic correlates of stigma in first-episode psychosis: the impact of duration of untreated psychosis. Acta Psychiatrica Scandinavica

Mueser KT, Meyer-Kalos, P.S., Glynn, S.M., Lynde, D.W., Robinson, D.G., Gingerich, S., Penn, D.L., Cather, C., Gottlieb, J.D., Marcy, P., & Wiseman, J.L. (2019). Implementation and fidelity assessment of the NAVIGATE treatment program for first episode psychosis in a multi-site study. Schizophrenia research204, 271-281.

Nishith, P., Mueser, K. T., & Morse, G. A. (2019). Alcohol expectancies in persons with severe mental illness and posttraumatic stress disorder. Cogent Medicine, 6, 1635805.

Schuster RM, Potter K, Vandrey R, Hareli M, Gilman JM, Schoenfeld D & Evins AE (2019). Urinary 11-nor-9-carboxy-tetrahydrocannabinol elimination in adolescent cannabis users during one month of sustained and biochemically-verified abstinence. Journal of Psychopharmacology. doi: 10.1177/0269881119872206.

Shapero, B.G., Farabaugh, A., Terechina, O., DeCross, S.N,, Cheung, J., Fava, M., Holt, D.J. (2019). Understanding the effects of emotional reactivity on depression and suicidal thoughts and behaviors: moderating effects of childhood adversity and resilience. J Affect Disord, 419-427. doi: 10.1016/j.jad.2018.11.033

Tidey J, Muscat J, Foulds J, Evins AE, Gaalema DE & Denlinger-Apte RL (2019). Reducing the nicotine content of cigarettes: Effects in smokers with mental health conditions and socioeconomic disadvantages. Nicotine & Tobacco Research. doi: 10.1093/ntr/ntz118.

Tuominen, L., Boeke, E.A., DeCross, S.N., Wolthusen, R.P.F., Nasr, S., Milad, M.M., Vangel, M., Tootell, R.B.H., Holt, D.J. (2019) The relationship of perceptual discrimination to neural mechanisms of fear generalization. NeuroImage, 445.

Valentine, S.E., Ahles, E.M., De Silva, L.E.D., Patrick, K.A., Baldwin, M., Chablani-Medley, A., Shtasel, D.L., & Marques, L. (2019). community-based implementation of a paraprofessional-delivered cognitive behavioral therapy program for youth involved with the criminal justice system. Journal of Health Care for the Poor and Underserved30(2), 841-865.

Vance, M., Bui, E., Shtasel, D., & Borba, C. (2019). Health advocacy among resident physicians. MedEdPublish8

Wright A, Browne JMueser KT & Cather C (2019). Evidence-based psychosocial treatment for individuals with early psychosis. Child and Adolescent Psychiatric Clinics of North America. doi: 10.1016/j.chc.2019.08.013.

Wright A, Cather C, Gilman J & Evins AE (2019). The changing legal landscape of cannabis use and its role in youth-onset psychosis. Child and Adolescent Psychiatric Clinics of North America. doi: 10.1016/j.chc.2019.08.016.

Wright AC, Fowler D & Greenwood K (2019). Influences on functional outcome and subjective recovery in individuals with and without first episode psychosis: A metacognitive model. Psychiatry Research. doi: 10.1016/j.psychres.2019.112643.

Wright AC, Nelson B, Fowler D & Greenwood K (2019). Perceptual biases and metacognition and their association with anomalous self experiences in first episode psychosis. Consciousness and Cognition. doi: 10.1016/j.concog.2019.102847.

Wright, A.C., Davies, G., Fowler, D., & Greenwood, K. (2019). Three-year follow-up study exploring metacognition and function in individuals with first episode psychosis. Frontiers in Psychiatry, 10, 182.

Wright, A.C.Mueser KT, McGurk, S.R., Fowler, D., & Greenwood, K. E. (2019). Cognitive and metacognitive factors predict engagement in employment in individuals with first episode psychosis. Schizophrenia Research: Cognition, 100141.

Yeh CL, Levar N, Broos HC, Dechert A, Potter K, Evins AE & Gilman JM (2019). White matter integrity differences associated with posttraumatic stress disorder are not normalized by concurrent marijuana use. Psychiatry Research: Neuroimaging. doi: 10.1016/j.pscychresns.2019.111017.

Youn S, Mackintosh M, Wiltsey Stirman S, Patrick KA, Aguilar Silvan Y, Bartuska AD, Shtasel DL & Marques L (2019). Client-level predictors of treatment engagement, outcome, and dropout: Moving beyond demographics. General Psychiatry. doi: 10.1136/gpsych-2019-100153.

Youn, S.J., Sauer-Zavala, S., Patrick, K.A., Ahles, E.M., Aguilar, S.Y., Greig, A., Marques, L., & Shtasel, D.L. (2019). Barriers and facilitators to implementing a short-term transdiagnostic mental health treatment for homeless persons. The Journal of Nervous and Mental Disease

Dalcin, A.T., Jerome, G.J., Appel, L.J., Dickerson, F.B., Wang, N.Y., Miller, E.R., Young, D.R., Charleston, J.B., Gennusa, J.V., Goldsholl, S., Heller, A., Evins, A.E., Cather, C., McGinty, E.E., Crum, R.M., & Daumit, G.L. (2018). Need for cardiovascular risk reduction in persons with serious mental illness: design of a comprehensive intervention. Frontiers in Psychiatry9

Published Books & Book Chapters

Click on a year to expand the list of books and book chapters. 

Mueser KT. (2024). Preface. In Hardy KV & Turkington D (Eds.), Decoding delusions: A clinician’s guide to working with delusions and other extreme beliefs (pp. xii-xviii). Washington, DC: American Psychiatric Association Publishing. 

Freudenreich O & Stern TA. (2023) Antipsychotic drugs. In: Stern TA & Fava M, Learning about psychopharmacology: A programmed text for multidisciplinary learners (pp. 145-205). Boston, MA: Massachusetts General Hospital Psychiatry Academy Publishing.

Roe D, Hasson-Ohayon I & Mueser KT. (2023). Psychiatric illness. In: Meade M, Bechtold K & Wegener S (Eds.), The Oxford handbook of rehabilitation psychology (Second edition). New York: Oxford.

Arntz D & Ray S (2022). Perceived discrimination in healthcare settings among Filipino Americans. In: Chin J, Garcia Y & Blume AW. (Eds.). Psychology of Inequity. Santa Barbara, CA, United States: Praeger Press.

Freudenreich O & Cather C. (2021). Facing Serious Mental Illness: A Guide For Patients And Their Families (Stern TA, Ed.). MGH Psychiatry Academy.

McGurk SR & Mueser KT. (2021). Thinking Skills for Work: Cognitive Enhancement for Successful Employment. New York: Guilford Press. 

Browne JMueser K & Pratt S (2020). Social skills training for persons with schizophrenia. In: Nangle DW, Erdley CA & Schwartz-Mette R (Eds.). Social Skills Across the Life Span: Theory, Assessment, and Intervention (pp. 330-342). London, England: Elsevier.

Freudenreich O, Donnelly-Boylen KM & Gandhi RT (2020). Infectious diseases and their psychiatric manifestations. In: Summergrad P, Silbersweig DA, Muskin PR & Querques J (Eds.). Textbook of Medical Psychiatry (pp. 265-268). Washington, DC: American Psychiatric Association Publishing.

McEvoy JP, Asuzu K, Bradford DW, Freudenreich O & Moyer KH (2020). Treatment and management of patients with schizophrenia. In: Geddes JR, Andreasen NC & Goodwin GM (Eds.). New Oxford Textbook of Psychiatry, 3rd Edition. Oxford, England: Oxford University Press.

Mueser KT & Lu W. (2020). Traumatic stress in special populations. In: Beck JG & Sloan DM (Eds.). The Oxford handbook of traumatic stress disorders (Second Edition). New York: Oxford University Press.

Baldelli-Pelletier, A., Holt, D.J. (2019). Deficits in social cognition and negative symptoms in schizophrenia. In Lewandowski KE, Moustafa AA (Ed) Social Cognition in psychosis. Elsevier: Philadelphia. 

Beckmann, D., Myrick, K.J., & Shtasel, D. (2019). Mental Illness, addiction, and incarceration: Breaking the cycle. In Medlock, M.M., Shtasel, D., Trinh, N.T. & Williams, D.R. (Eds.), Racism and psychiatry (pp. 71-86). Humana Press: Cham. 

Brown HE, Kaneko Y & Donovan AL (2019). Substance-induced psychosis and co-occurring psychotic disorders (pp. 111-124). In: Donovan AL & Bird SA (Eds). Substance use and the acute psychiatric patient: Emergency management. Cham, Switzerland: Humana Press.

Gingerich, S., Mueser, K. T., Boggian, I., Lamonaca, D., Merlin, S., & Soro, G. (2019). Training per le abilità di coping: Una guida pratica (in English: Training in coping skills: A practical guide). Rome: Giovanni Fioriti Editore. 

Hardy, K. V., Landa, Y., Meyer-Kalos, P., & Mueser, K. T. (2019). Psychotherapeutic interventions for early psychosis. In K. V. Hardy, J. S. Ballon, D. L. Noordsy & S. Adelsheim (Eds.), Intervening early in psychosis: A team approach (pp. 211-39). Washington, DC: American Psychiatric Publishing. 

Medlock, M.M., Shtasel, D., Trinh, N.H.T., & Williams, D.R. (Eds.). (2019). Racism and Psychiatry: Contemporary Issues and Interventions. New York: Springer International Publishing. 

Shtasel, D., Carlo, A.D., & Trinh, N.H.T. (2019). Medical education and racism: Where have we been and where might we go?. In Racism and psychiatry: Contemporary issues and interventions. (pp. 205-216). Humana Press: Cham. 

Wittmann, Donovan AL & Nisavic M (2019). Alcohol and sedative use disorders and related emergencies (pp. 27-50). In: Donovan AL & Bird SA (Eds). Substance use and the acute psychiatric patient: Emergency management. Cham, Switzerland: Humana Press.

Zhu Y, Gilman JM, Evins AE & Sabuncu M (2019). Detecting cannabis-associated cognitive impairment using resting-state fNIRS (pp. 146-154). In: Shen D et al. (Eds). Medical image computing and computer assisted intervention – MICCAI 2019. Cham, Switzerland: Springer.



Your donation will support our mission to develop and implement life-changing interventions.